Lawrence McDonald: Russian Market Too Cheap to Pass Up

By on March 7, 2014

Lawrence McDonald - Newedge GroupLawrence McDonald, Senior Director at Newedge Group, told Brian Sullivan that emerging markets have become cheap, with the Russian market being a particular standout in the bargain bin.

McDonald is author of A Colossal Failure of Common Sense: The Inside Story of the Collapse of Lehman Brothers
and cites two reasons as to why he believes emerging markets are currently attractive.

1. Seventeen weeks of outflows from emerging markets

During the first two months of 2014, $11.3 billion have left emerging market equity and bond exchange traded funds, reflecting the overall sentiment of worldwide investors. McDonald sees this as mirroring similar outflows in developed markets that subsequently rebounded significantly.

“What we’ve seen at the great market bottoms – in the United States, 2009; Europe, 2012 – [is] a surge in outflows,” says McDonald. “What’s happening now in emerging markets is historic and it’s right on proportion with the 2012 bottom in Europe and 2009 bottom in the United States.”

2. Lowest valuations for emerging markets since 9/11

Though emerging markets are considered relatively risky, particularly in this environment, McDonald believes they are being over-discounted. He believes investors worried about buying emerging market stocks should heed the words of Seth Klarman, founder of hedge fund Baupost Group, who once said, “Buying right never feels good.”

“If you look at the emerging markets now, they are trading at a great valuation with a lot of with a lot of risks in the world,” says McDonald. “On a price-to-book [basis], they’re at 1.3 times book [value]. Developed markets like Europe and the United States are well above 2.2 to 2.3 times book. But, within the emerging markets, countries like Russia are trading at half of book and that’s too cheap to pass up.

While McDonald acknowledges that fear of instability in places like Russia given the current political climate may be a reason for the deep discount to its stocks, he believes that’s overdone. As an example, he points to the Market Vectors Russia ETF (RSX).

“The RSX fund has 32 million shares outstanding,” says McDonald. “On Monday, 25 million traded. That’s the type of thing you see when a biotech company misses earnings or has a failed trial. This isn’t a biotech; this is a country’s stocks which is mind-boggling. So, I don’t think there’s anybody left to sell these names.”

5 Comments

  1. The Master

    March 10, 2014 at 7:29 pm

    Too much corruption makes them cheap for a reason.

  2. Herbie Versmels

    March 11, 2014 at 2:44 pm

    The earth has been around for approximately 5,000 years; more than sufficient time for “emerging” markets to have emerged. These places are nothing more than dins of sin and an affront to our Lord. USA biotech is the place to be invested.

  3. Younis

    March 13, 2014 at 3:58 pm

    Russkies were much cheaper in 2009 – what seems low nearly always goes lower. It is still too soon to buy here despite the incredible trading volumes.

  4. Haywood Jablomi

    March 20, 2014 at 8:06 pm

    Younis, the S&P was much lower in 2009 too.

  5. Swayze, Patrick

    March 22, 2014 at 3:28 pm

    All of you are red lovers and a disgrace to free people. Pray you don’t wander into my crosshairs.

    Wolverines!

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>